Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Head and Neck Neoplasms × Particle Accelerators × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pelvic Neoplasms 1 Pancreatic Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Acute Toxic Effects 1

Interventions

Cisplatin 117 Radiotherapy 102 Cetuximab 78 Docetaxel 53 Radiotherapy, Intensity-Modulated 48 Surveys and Questionnaires 38 Carboplatin 38 Paclitaxel 36 pembrolizumab 35 Fluorouracil 33 Radiation 27 Blood Specimen Collection 24 Drug Therapy 21 Nivolumab 17 Erlotinib Hydrochloride 16 Surgical Procedures, Operative 14 Magnetic Resonance Spectroscopy 14 Standard of Care 13 Pemetrexed 13 Gemcitabine 12 durvalumab 11 Low-Level Light Therapy 11 Everolimus 11 Bevacizumab 11 Amifostine 11 Radiosurgery 10 Immunohistochemistry 10 Exercise 10 Celecoxib 10 Gefitinib 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04379505 2023-12-08

PEAQ-RT

Washington University School of Medicine

Phase NA Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡